245 related articles for article (PubMed ID: 21804090)
21. Activation of NFAT signaling in podocytes causes glomerulosclerosis.
Wang Y; Jarad G; Tripathi P; Pan M; Cunningham J; Martin DR; Liapis H; Miner JH; Chen F
J Am Soc Nephrol; 2010 Oct; 21(10):1657-66. PubMed ID: 20651158
[TBL] [Abstract][Full Text] [Related]
22. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1.
Gebeshuber CA; Kornauth C; Dong L; Sierig R; Seibler J; Reiss M; Tauber S; Bilban M; Wang S; Kain R; Böhmig GA; Moeller MJ; Gröne HJ; Englert C; Martinez J; Kerjaschki D
Nat Med; 2013 Apr; 19(4):481-7. PubMed ID: 23502960
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
[TBL] [Abstract][Full Text] [Related]
24. First identification of
Lin FJ; Yao L; Hu XQ; Bian F; Ji G; Jiang GR; Gale DP; Ren HQ
Clin Sci (Lond); 2019 Jan; 133(1):9-21. PubMed ID: 30523047
[TBL] [Abstract][Full Text] [Related]
25. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.
Shi SF; Wang SX; Zhang YK; Zhao MH; Zou WZ
Ren Fail; 2008; 30(5):477-83. PubMed ID: 18569926
[TBL] [Abstract][Full Text] [Related]
26. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
[TBL] [Abstract][Full Text] [Related]
27. Rho-GTPase Activating Protein myosin MYO9A identified as a novel candidate gene for monogenic focal segmental glomerulosclerosis.
Li Q; Gulati A; Lemaire M; Nottoli T; Bale A; Tufro A
Kidney Int; 2021 May; 99(5):1102-1117. PubMed ID: 33412162
[TBL] [Abstract][Full Text] [Related]
28. Podocyte-specific loss of Cdc42 leads to congenital nephropathy.
Scott RP; Hawley SP; Ruston J; Du J; Brakebusch C; Jones N; Pawson T
J Am Soc Nephrol; 2012 Jul; 23(7):1149-54. PubMed ID: 22518006
[TBL] [Abstract][Full Text] [Related]
29. Enhanced Levels of Glycosphingolipid GM3 Delay the Progression of Diabetic Nephropathy.
Naito S; Nakayama K; Kawashima N
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511118
[TBL] [Abstract][Full Text] [Related]
30. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
[TBL] [Abstract][Full Text] [Related]
31. Vinculin is required to maintain glomerular barrier integrity.
Lausecker F; Tian X; Inoue K; Wang Z; Pedigo CE; Hassan H; Liu C; Zimmer M; Jinno S; Huckle AL; Hamidi H; Ross RS; Zent R; Ballestrem C; Lennon R; Ishibe S
Kidney Int; 2018 Mar; 93(3):643-655. PubMed ID: 29241625
[TBL] [Abstract][Full Text] [Related]
32. Epithelial cell foot process effacement in podocytes in focal and segmental glomerulosclerosis: a quantitative analysis.
Kfoury H
Ultrastruct Pathol; 2014 Oct; 38(5):303-8. PubMed ID: 24956069
[TBL] [Abstract][Full Text] [Related]
33. Loss of phosphatidylserine flippase β-subunit Tmem30a in podocytes leads to albuminuria and glomerulosclerosis.
Liu W; Peng L; Tian W; Li Y; Zhang P; Sun K; Yang Y; Li X; Li G; Zhu X
Dis Model Mech; 2021 Jun; 14(6):. PubMed ID: 34080006
[TBL] [Abstract][Full Text] [Related]
34. Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis.
El-Aouni C; Herbach N; Blattner SM; Henger A; Rastaldi MP; Jarad G; Miner JH; Moeller MJ; St-Arnaud R; Dedhar S; Holzman LB; Wanke R; Kretzler M
J Am Soc Nephrol; 2006 May; 17(5):1334-44. PubMed ID: 16611717
[TBL] [Abstract][Full Text] [Related]
35. Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases.
Kubo A; Hidaka T; Nakayama M; Sasaki Y; Takagi M; Suzuki H; Suzuki Y
BMC Nephrol; 2020 Sep; 21(1):402. PubMed ID: 32948146
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of the homophilic adhesion molecule sidekick-1 in podocytes contributes to glomerulosclerosis.
Kaufman L; Potla U; Coleman S; Dikiy S; Hata Y; Kurihara H; He JC; D'Agati VD; Klotman PE
J Biol Chem; 2010 Aug; 285(33):25677-85. PubMed ID: 20562105
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Importin- α -Mediated Nuclear Localization of Dendrin Attenuates Podocyte Loss and Glomerulosclerosis.
Empitu MA; Kikyo M; Shirata N; Yamada H; Makino SI; Kadariswantiningsih IN; Aizawa M; Patrakka J; Nishimori K; Asanuma K
J Am Soc Nephrol; 2023 Jul; 34(7):1222-1239. PubMed ID: 37134307
[TBL] [Abstract][Full Text] [Related]
38. Progression of albuminuria and podocyte injury in focal segmental glomerulosclerosis inhibited by enhanced glycosphingolipid GM3 via valproic acid.
Kawashima N; Naito S; Nagane M; Yamashita T; Nakayama KI
Sci Rep; 2023 Dec; 13(1):22487. PubMed ID: 38110538
[TBL] [Abstract][Full Text] [Related]
39. The spectrum of focal segmental glomerulosclerosis: new insights.
D'Agati VD
Curr Opin Nephrol Hypertens; 2008 May; 17(3):271-81. PubMed ID: 18408478
[TBL] [Abstract][Full Text] [Related]
40. Podocyte-specific Crb2 knockout mice develop focal segmental glomerulosclerosis.
Tanoue A; Katayama K; Ito Y; Joh K; Toda M; Yasuma T; D'Alessandro-Gabazza CN; Kawachi H; Yan K; Ito M; Gabazza EC; Tryggvason K; Dohi K
Sci Rep; 2021 Oct; 11(1):20556. PubMed ID: 34654837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
